Menière's Disease or Ménière's Disease or Meniere's Disease?
T Nakashima, K Tsuzuki, K Sugiyama - Practica Oto-Rhino-Laryngologica, 2018
抄録 Prosper Menière published his famous original paper about vertigo in 1861. Since
then, his name has appeared in the literature spelled in several different ways, such as
Ménière, Menière or Meniere. Previously, Menière was the most commonly used in Europe,
then, his name has appeared in the literature spelled in several different ways, such as
Ménière, Menière or Meniere. Previously, Menière was the most commonly used in Europe,
 |  |  |
PHARMACEUTICAL COMPOSITION COMPRISING BOTULINUM, A NON IONIC SURFACTANT, SODIUM CHLORIDE AND SUCROSE
P Webb, M White, J Partington - US Patent 20,170,348,226, 2017
… otorhinolaryngological disorders including spasmodic dysphonia, hypersalivation, sialorrhoea,
otic disorders, hearing impairment, ear click, tinnitus, vertigo, Meniere's disease, cochlear nerve
dysfunction, stuttering, cricopharyngeal dysphagia, bruxism, closure of larynx in …
otic disorders, hearing impairment, ear click, tinnitus, vertigo, Meniere's disease, cochlear nerve
dysfunction, stuttering, cricopharyngeal dysphagia, bruxism, closure of larynx in …
| | |
Biomechanical and stress distribution effects of maxillary expansion methods (sarpe, marpe, dome) using finite element model
YF Chen, A Yoon, HC Chang, SYC Liu, YC Chen - Sleep Medicine, 2017
… We excluded patients who were diagnosed with sleep apnea younger than age 20, those
who had antecedent hearing loss, Meniere's disease, vestibular schwannoma, or tinnitus.
The study endpoint for both cohorts was the diagnosis of first tinnitus …
who had antecedent hearing loss, Meniere's disease, vestibular schwannoma, or tinnitus.
The study endpoint for both cohorts was the diagnosis of first tinnitus …
| | |
Increased risk of tinnitus in patients with sleep apnea: a nationwide population-based study
YT Chen, LK Huon, SYC Liu - Sleep Medicine, 2017
… We excluded patients who were diagnosed with sleep apnea younger than age 20, those
who had antecedent hearing loss, Meniere's disease, vestibular schwannoma, or tinnitus.
The study endpoint for both cohorts was the diagnosis of first tinnitus …
who had antecedent hearing loss, Meniere's disease, vestibular schwannoma, or tinnitus.
The study endpoint for both cohorts was the diagnosis of first tinnitus …
| | |
Sleep apnea does not increase risk of diabetic retinopathy: a nationwide population-based study
YT Chen, LK Huon, SYC Liu - Sleep Medicine, 2017
… We excluded patients who were diagnosed with sleep apnea younger than age 20, those
who had antecedent hearing loss, Meniere's disease, vestibular schwannoma, or tinnitus.
The study endpoint for both cohorts was the diagnosis of first tinnitus …
who had antecedent hearing loss, Meniere's disease, vestibular schwannoma, or tinnitus.
The study endpoint for both cohorts was the diagnosis of first tinnitus …
| | |
[HTML] Vertigo, Defination, Causes, Sign-symptom, Treatment, exercise, Home advice
MHA Rashid
… Disorders include Meniere's disease, benign paroxysmal positional vertigo (BPPV) and vestibular
neuritis … The most common causes that lead to vertigo are BPPV, also known as the paroxysmal
positional vertigo as well as the vestibular neuritis or Meniere's disease …
neuritis … The most common causes that lead to vertigo are BPPV, also known as the paroxysmal
positional vertigo as well as the vestibular neuritis or Meniere's disease …
| | |
[PDF] Role of epley's manoeuvre in BPPV treatment: Our experience
GF Hongal, MH Sathyalakshmi
… Though BPPV is some times resolves without any treatment definitive treatment consists of Epley's
Manoeuvre [2]. Most of the time cause for BPPV is Idiopathic sometimes can be caused by trauma
to head, otitis media, vestibular neuronitis, Meniere's disease, sudden …
Manoeuvre [2]. Most of the time cause for BPPV is Idiopathic sometimes can be caused by trauma
to head, otitis media, vestibular neuronitis, Meniere's disease, sudden …
| | |
Anti-IgE Therapy
AD Maderal, B Berman - Biologic and Systemic Agents in Dermatology, 2018
Omalizumab is an anti-immunoglobulin E (IgE) therapy indicated for moderate
to severe persistent asthma and chronic spontaneous or idiopathic urticaria,
with several other potential uses in dermatolog.
to severe persistent asthma and chronic spontaneous or idiopathic urticaria,
with several other potential uses in dermatolog.
| | |
The effect of industry delocalization on global energy use: A global sectoral perspective
S Forin, A Radebach, JC Steckel, H Ward - Energy Economics, 2018
Sectoral production technologies differ largely across countries, so do sectoral energy
intensities. Hence, shifts in production locations within global sectors.
intensities. Hence, shifts in production locations within global sectors.
| | |
GLYCAN-BASED ANTIBODY-DRUG CONJUGATES
R Davidson, B Gong - US Patent 20,170,362,338, 2017
Genetically engineered antibodies containing non-native N-glycosylated
sites, preparation of the antibodies in yeast and fungi, site-specific
conjugation of drugs to these antibodies, and methods of t.
sites, preparation of the antibodies in yeast and fungi, site-specific
conjugation of drugs to these antibodies, and methods of t.
| | |
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου